Physician profile
Allen Flood
NPI 1033151758
$942.21
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $165 · 2021: $351 · 2022: $40.28.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $257.84 | 2019-2021 | |
| Galderma Laboratories, L.P. | $197.38 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $125.26 | 2019 | |
| Abbvie INC. | $91.36 | 2020-2021 | |
| Mission Pharmacal Company | $72.34 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $70.22 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $60.52 | 2021-2022 | |
| Leo Pharma INC. | $31.29 | 2021 | |
| Paratek Pharmaceuticals, INC. | $18.80 | 2021 | |
| Almirall LLC | $17.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Flood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.